If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
11
Followers on Owler
NEP researches and develops peptides, polyclonal antibodies and stable isotopes for the life sciences market...
Read more
Overview
Competitors
Funding
News & Insights
NEP researches and develops peptides, polyclonal antibodies and stable isotopes for the life sciences market...
Read more
CEO
Martina Diekmann
CEO Approval Rating
90/100
Weigh In
1998
Gardner
Massachusetts
Greater Boston
Private
Pharmaceuticals & Biotechnology
Biotechnology
Pharmaceuticals
2836
NAICS listing
https://www.newenglandpeptide.com/
Est. Annual Revenue
$25-100M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Oct 29, 2020
StreetInsider
Press Release: NEP : New England Peptide Receives Massachusetts Manufacturer of the Year Award
Mar 09, 2020
cfomoves
NEP: David Gavlik joins as Chief Financial Officer.
Mar 05, 2020
StreetInsider
Press Release: NEP : New England Peptide Announces the Appointment of Dr. Martina Diekmann as CEO and David Gavlik as CFO
Oct 10, 2019
FinSMEs
NEP: New England Peptide Receives Equity Investment From Ampersand Capital Partners
May 29, 2015
PRWEB
Press Release: NEP : New England Peptide Announces New Tryptides Catalog
Mar 29, 2015
WORCESTER TELEGRAM & GAZETTE
NEP: Relationships matter as biotech company builds upon its growth
Jun 11, 2014
PRWEB
Press Release: NEP : New England Peptide, Inc. and SISCAPA Assay Technologies, Inc. Announce Peptide Stable Isotope Standard Collaboration
May 05, 2014
PRWEB
Press Release: NEP : New England Peptide Opens New Business Office in Cambridge, MA
Follow and Get Alerts
New England Peptide, Inc. Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
Unlock 4 + competitors
Trending Companies